Share
Market Research Report

ASTHMA THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Drug ClassCorticosteroids · Beta2-Agonists (Long-acting and Short-acting) · Leukotriene Inhibitors · Long-acting Muscarinic Antagonists (LAMA) · Interleukin Antagonists · Anti-immunoglobulin E (IgE) Agents · Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids, and Others) · and Others
  • By Route of AdministrationOral · Inhalation · and Injection
  • By Distribution ChannelHospitals Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In30 Jan 2026
  • Report CodeCMI2698
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Technology Advancements
    • Epidemiology
    • Product Recalls
    • Government Initiatives
    • Historical Overview
    • Merger and Acquisition
    • Regulatory and Reimbursement Scenario
    • PORTER’S Five Forces
    • PEST Analysis
  4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Corticosteroids
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Beta2-Agonists (Long-Acting and Short-Acting)
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Leukotriene Inhibitors
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Long-Acting Muscarinic Antagonists (LAMA)
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Interleukin Antagonists
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Anti-Immunoglobulin E (IgE) Agents
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Combination Products
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Others
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
  5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)

    • Oral
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Inhalation
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Injection
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
  6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Hospitals Pharmacies
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Retail Pharmacies
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
    • Online Pharmacies
      • Market Share Analysis, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 - 2033
      • Segment Trends
  7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2021 - 2033
    • North America
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
      • Market Size and Forecast By Country, 2026-2033, (USD Bn)
        • US.
        • Canada
    • Europe
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
      • Market Size and Forecast By Country, 2026-2033, (USD Bn)
        • UK.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
      • Market Size and Forecast By Country, 2026-2033, (USD Bn)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
      • Market Size and Forecast By Country, 2026-2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
      • Market Size and Forecast By Country, 2026-2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
      • Y-o-Y Growth Analysis, For Country, 2021 - 2033
      • Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
      • Market Size and Forecast By Country, 2026-2033, (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
      • GlaxoSmithKline Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Philips Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • AstraZeneca Plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Boehringer Ingelheim GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sanofi- Aventis SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • CareFusion Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Sunovion Pharmaceutical Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck & Co. Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Roche Diagnostics
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  9. Section

    • References
    • Research Methodology
    • About us and Sales Contact